| Metric | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue | ¥10877.4B | ¥11278.8B | -3.6% |
| Operating Income | ¥498.7B | ¥-640.1B | +0.3% |
| Ordinary Income | ¥434.1B | ¥-791.6B | +154.8% |
| Net Income | ¥318.4B | ¥-503.2B | +163.3% |
| ROE | 5.8% | -10.6% | - |
Q2 results for the fiscal year ended March 2026 showed Revenue of ¥10,877B (YoY -¥401B, -3.6%), Operating Income of ¥499B (YoY +¥1,139B, turned to profit), Ordinary Income of ¥76B (YoY -¥79B, -50.9%), and Net Income attributable to owners of the parent of ¥318B (YoY +¥818B, +163.3%). Revenue declined due to demand slowdown in the U.S. and China, but Operating Income returned to profit as the prior year's large impairment charge (¥523B) rolled off, gross margin improved to 44.0% (from 42.5% YoY, +1.5pt), and SG&A ratio declined to 39.1% (from 39.7% YoY, -0.6pt). Ordinary Income was weighed down from Operating Income by financial expenses of ¥113B and other expenses of ¥107B, but Net Income recovered substantially from a prior-year loss due to appropriate tax burden and reduction in discontinued operations losses. Operating Cash Flow was ¥863B (YoY +69%), generating 2.7x Net Income, and Free Cash Flow was ¥523B — sufficient to cover capital expenditures and dividends.
[Revenue] Revenue was ¥10,877B (YoY -3.6%), a decline. By region, the U.S. was ¥2,775B (-7.1%), China ¥894B (-13.3%) with marked demand slowdown, Europe ¥3,498B (-1.1%) roughly flat, and Japan ¥1,742B (+0.7%) slight increase. By segment, Digital Workplace Business was ¥6,105B (-1.0%) — core but slightly down; Professional Print Business was ¥2,552B (-10.4%) with double-digit decline; Industry Business was ¥1,268B (+6.3%) maintaining growth; Imaging Solution Business was ¥945B (-11.6%) with significant decline. Gross profit margin was 44.0% (YoY +1.5pt) as price revisions, mix improvement, and cost reductions helped offset revenue declines.
[Profitability] Cost of sales was ¥6,093B (cost of sales ratio 56.0%), down ¥552B YoY, securing gross profit of ¥4,784B. SG&A was ¥4,252B (SG&A ratio 39.1%, YoY -¥222B) reflecting efficiency gains, and Operating Income was ¥499B (Operating margin 4.6%), a turnaround from last year’s operating loss of ¥640B. Last year included impairment losses of ¥521B, whereas this period was limited to ¥10B, removing a one-off factor. Non-operating items showed financial income of ¥48B against financial expenses of ¥113B, and other income of ¥74B against other expenses of ¥107B, resulting in non-operating and other expense net burden of ¥98B; Ordinary Income was therefore ¥76B (YoY -50.9%). Profit Before Tax was ¥434B; after deducting income taxes of ¥96B, profit from continuing operations was ¥338B, less discontinued operations loss of ¥19B resulted in Net Income of ¥318B. Overall, the company achieved a structure of lower revenues but higher profitability.
Digital Workplace Business: Revenue ¥6,105B (-1.0%), Operating Income ¥371B (+165.2%), Operating margin 6.1%. Demand in the core office multifunction device market is flat, but the roll-off of last year’s impairment and cost reductions drove substantial profit growth. Professional Print Business: Revenue ¥2,552B (-10.4%), Operating Income ¥93B (+170.8%), Operating margin 3.7%. Revenue fell with commercial printing demand slowdown, but structural reforms and margin improvements delivered profit increases. Industry Business: Revenue ¥1,268B (+6.3%), Operating Income ¥223B (+274.7%), Operating margin 17.6%, showing the highest profitability company-wide. Growth in measuring instruments, functional materials, and industrial inkjet heads drove revenue and profit growth and made this segment a primary profit contributor. Imaging Solution Business: Revenue ¥945B (-11.6%), Operating loss ¥13B (loss narrowed from ¥258B the prior year), Operating margin -1.4%. Revenue fell due to lower demand for medical imaging systems and network cameras, but the roll-off of last year’s large impairment and business efficiency improvements significantly reduced the loss.
[Profitability] ROE improved significantly to 6.1% (from -9.5% prior year), Operating margin was 4.6% (improved +10.3pt from -5.7% prior year) as last year’s large impairment rolled off and gross margin improved. Net margin was 2.9% (improved +7.4pt from -4.5% prior year), indicating normalization of profitability. Gross margin 44.0% (from 42.5% prior year, +1.5pt) benefited from price adjustments and cost reductions; SG&A ratio 39.1% (from 39.7% prior year, -0.6pt) reflected efficiency gains. Industry Business operating margin of 17.6% lifted the company average. [Cash quality] Operating Cash Flow ¥863B generated 2.7x Net Income ¥318B; Free Cash Flow ¥523B sufficiently covered capital expenditure ¥479B and dividends ¥24B, indicating solid cash generation. Operating CF/EBITDA ratio was 79.5% suggesting room to improve cash conversion efficiency, while inventory reduction of ¥150B and receivables compression of ¥24B contributed to working capital improvement. [Investment efficiency] Total asset turnover was 0.881x (down from 0.927x prior year) showing some slowing and room for efficiency improvement. Capital expenditure ¥479B was below depreciation ¥587B, indicating conservative capex. [Financial soundness] Equity Ratio was 43.4% (improved +5.4pt from 38.0% prior year) as internal reserves accumulated, strengthening the financial position. Interest-bearing debt (bonds & borrowings + lease liabilities) was ¥3,983B, Debt/EBITDA approximately 3.7x—relatively high; Interest Coverage (Operating Income / Financial expenses) about 4.4x, so sensitivity to interest burden remains. Current ratio approximately 176% and liquidity is healthy with cash and deposits of ¥1,108B.
Operating CF was ¥863B (YoY +69%), a large increase generating 2.7x Net Income ¥318B. Operating CF subtotal (before working capital changes) was ¥1,033B, with depreciation ¥587B forming the cash generation base. In working capital, inventory decrease of ¥150B and trade receivables decrease of ¥24B generated cash, while trade payables decrease of ¥145B partially offset this. Corporate tax payments ¥96B, interest paid ¥108B, and lease payments ¥216B dampened cash generated by working capital improvement. Investing CF was -¥340B: capital expenditure ¥479B and intangible asset acquisitions ¥132B were offset by proceeds from sale of investment securities ¥213B and disposal of subsidiaries ¥57B. Financing CF was -¥403B: repayments of short-term borrowings ¥290B and redemption/repayment of bonds & long-term borrowings ¥334B were financed by new borrowings and bond issuance ¥476B, and the company made lease liability repayments ¥216B and dividend payments ¥24B. Foreign exchange translation effects contributed +¥59B, increasing cash and cash equivalents from ¥929B at the beginning of the period to ¥1,108B at the end — an increase of ¥179B. Free Cash Flow ¥523B is sufficient to cover dividends and debt repayments, and demonstrates ongoing cash generation not reliant on transient working capital releases.
Overall quality of earnings is generally good. Operating Income ¥499B normalized as last year’s large impairment loss (¥523B) rolled off and current period impairment was limited to ¥10B. Recurring earnings were supported by a 1.5pt gross margin improvement and SG&A reductions, with limited impact from one-off items. In non-operating items, financial expenses ¥113B exceeded financial income ¥48B, resulting in a net burden of ¥65B, and other expenses ¥107B (prior year ¥1,080B) also pressured Operating Income but have substantially decreased from large prior-year expense recognition. The gap between Operating Income ¥499B and Ordinary Income ¥76B reflects the drag from non-operating and other expenses; continuing financial expenses constrain growth at the ordinary income stage. Operating CF ¥863B generated 2.7x Net Income ¥318B, and the accrual ratio was -4.5%, indicating good cash realization and high quality of earnings. Comprehensive income was ¥792B, well above Net Income ¥318B; the bulk of other comprehensive income ¥473B was translation differences of ¥438B from overseas operations, benefiting from yen depreciation. The divergence between Ordinary Income and Net Income narrowed due to reduced tax burden, and overall the quality of Net Income is favorable.
Full year guidance projects Revenue ¥11,050B (YoY +1.6%), Operating Income ¥500B (YoY +0.3%), Net Income attributable to owners of the parent ¥285B (YoY -10.5%), and EPS ¥57.67. H1 cumulative results were Revenue ¥10,877B (progress 98.4%), Operating Income ¥499B (progress 99.7%), Net Income ¥318B (progress 111.6%), indicating Operating Income has nearly reached the full-year plan. The company’s forecast assumes a gradual recovery in U.S. and China demand and stability in Europe and Japan, with continued cost reduction effects and price maintenance keeping Operating Income flat. However, Net Income is conservatively projected lower assuming expansion of discontinued operations losses. The plan is prudent, incorporating continued interest burden and non-operating expense headwinds.
Annual dividend is ¥12 (interim ¥5, year-end ¥7), with a Payout Ratio of 19.6% — a healthy level. Against Free Cash Flow ¥523B, dividend payments ¥24B imply dividend-to-FCF coverage of approximately 21.9x, indicating ample capacity. Full year dividend forecast is ¥9, below the current period result, reflecting conservative policy and emphasis on flexible capital allocation based on next-year profit levels and investment plans. No share buyback disclosure; the current policy focuses on dividends. Given good cash realization, there is scope to expand shareholder returns depending on future operating performance.
Structural decline in office printing demand: The Digital Workplace Business accounts for 56.1% of Revenue and continues to decline slightly (YoY -1.0%). Digitalization and remote work penetration exert structural shrinkage pressure on the office MFP market. The company is responding with price maintenance and increasing service ratio, but slower volume growth poses a risk to company-wide growth. High concentration in revenue composition makes developing alternative growth engines a key challenge.
Interest burden and cost of capital headwind: With interest-bearing debt of ¥3,983B and financial expenses of ¥113B, the effective interest rate is about 2.8%; Interest Coverage is about 4.4x with limited buffer. Debt/EBITDA around 3.7x is relatively high, and rising interest rates would increase interest payments and pressure profitability at the ordinary income stage. The structure where most of Operating Income ¥499B is eroded by financial and non-operating expenses leaving Ordinary Income ¥76B demonstrates high interest sensitivity.
Working capital efficiency deterioration and growth slowdown risk: Trade receivables ¥3,166B imply DSO of about 106 days, inventory ¥2,105B implies DIO about 126 days, and CCC about 129 days — working capital efficiency has substantial room for improvement compared with manufacturing peers. Total asset turnover 0.881x (down from 0.927x) indicates declining asset efficiency; receivables and inventory stagnation hinder asset efficiency and ROE improvement. Without optimization of working capital, in periods of weak sales growth cash flow and ROA improvements may lag.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| ROE | 6.1% | 6.3% (3.2%–9.9%) | -0.2pt |
| Operating Margin | 4.6% | 7.8% (4.6%–12.3%) | -3.2pt |
| Net Margin | 2.9% | 5.2% (2.3%–8.2%) | -2.3pt |
Profitability is slightly below the manufacturing industry median, with Operating Margin trailing the industry median by -3.2pt, indicating substantial room for improvement.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth (YoY) | -3.6% | 3.7% (-0.4%–9.3%) | -7.3pt |
Revenue growth lags the industry median significantly, affected by demand slowdown in the core business and softness in U.S./China markets.
※ Source: Company compilation
Operating Margin normalized to 4.6% and returned to profit due to the roll-off of last year’s large impairment and gross margin improvement (+1.5pt) and SG&A ratio improvement (-0.6pt). Industry Business operating margin 17.6% drives company profitability, while Imaging Solution Business only narrowed losses, creating profitability dispersion across segments that determines the company average. Financial expenses ¥113B and non-operating expenses suppress growth at the ordinary income stage, and the decline from Operating Income ¥499B to Ordinary Income ¥76B is a structural issue. Reducing interest burden and managing non-operating expenses are key to future bottom-line improvement.
Operating CF ¥863B generated 2.7x Net Income and Free Cash Flow ¥523B sufficiently covered capex and dividends, demonstrating strong cash generation. Inventory reduction ¥150B and receivables compression ¥24B contributed to working capital improvement, but DSO 106 days, DIO 126 days, and CCC 129 days remain below manufacturing averages. Decline in total asset turnover to 0.881x also indicates need to improve asset efficiency; further compression of inventory and receivables and improving turnover will be the next steps to raise ROE. With Debt/EBITDA around 3.7x and Interest Coverage about 4.4x, sensitivity to interest burden is high; both working capital efficiency improvement and interest-bearing debt reduction are needed to strengthen the financial profile and raise ROE.
This report was auto-generated by AI analyzing XBRL financial statement data. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company from public financial statements. Investment decisions are your responsibility; consult a professional as necessary.